Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.78 Billion | USD 12.06 Billion | 9.7% | 2024 |
FrequentlyAsked Questions
Pet cancer therapeutics is a new anti-cancer medicine having the capacity to reduce the negative impact of cancer tissues.
The global pet cancer therapeutics market is expected to grow due to increasing pet ownership, rising awareness of veterinary oncology, and advancements in targeted therapies and diagnostics.
According to a study, the global pet cancer therapeutics market size was worth around USD 4.78 billion in 2024 and is expected to reach USD 12.06 billion by 2034.
The global pet cancer therapeutics market is expected to grow at a CAGR of 9.7% during the forecast period.
North America is expected to dominate the pet cancer therapeutics market over the forecast period.
Leading players in the global pet cancer therapeutics market include Karyopharm Therapeutics Inc., Zoetis, Oasmia Pharmaceuticals AB, Zenoaq, AB Science, Aratana Therapeutics Inc., Rhizen Pharmaceuticals SA, Morphogenesis Inc., Boehringer Ingelheim International GmbH, Regeneus Ltd., and VetDC Inc., among others.
The report explores crucial aspects of the pet cancer therapeutics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed